Consort Medical PLC Director/PDMR Shareholding (7672I)

TIDMCSRT

RNS Number : 7672I

Consort Medical PLC

21 June 2017

Consort Medical plc

Director Shareholding

21 June 2017

Consort Medical plc (the 'Company') announces that Paul Hayes, Chief Financial Officer purchased 4,000 ordinary 10p shares at a price of GBP10.9445 per share on 20 June 2017. Following this transaction Mr Hayes holds 8,000 ordinary shares in the Company.

The Notification of Dealing Form set out below is provided in accordance with the requirements of the Market Abuse Regulation.

 
 1     Details of the person discharging managerial 
        responsibilities / person closely associated 
----  ----------------------------------------------------------------- 
 a)    Name                           Paul Hayes 
----  -----------------------------  ---------------------------------- 
 2     Reason for the notification 
----  ----------------------------------------------------------------- 
 a)    Position/status                Chief Financial Officer 
----  -----------------------------  ---------------------------------- 
 b)    Initial notification           Initial Notification 
        /Amendment 
----  -----------------------------  ---------------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  ----------------------------------------------------------------- 
 a)    Name                           Consort Medical plc 
----  -----------------------------  ---------------------------------- 
 b)    LEI                            2138001TBP74FD66QT38 
----  -----------------------------  ---------------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  ----------------------------------------------------------------- 
 a)    Description of                 Ordinary Shares of 10p each 
        the financial 
        instrument, type 
        of instrument 
---- 
 
       Identification                 ISIN: GB0000946276 
        code 
 
 b)    Nature of the                  Acquisition 
        transaction 
----  -----------------------------  ---------------------------------- 
 c)    Price(s) and volume(s) 
----                                  -----------------  ------------ 
                                       Price(s)           Volume(s) 
----                                  -----------------  ------------ 
    GBP10.9445                                            4,000 
   ----------------------------------------------------  ------------ 
 
 d)    Aggregated information 
---- 
   n/a single transaction 
 
  - Aggregated volume 
 
  - Price 
 
 e)    Date of the transaction        2017-06-20 
----  -----------------------------  ---------------------------------- 
 f)    Place of the transaction       London Stock Exchange Main 
                                       Market (XLon) 
----  -----------------------------  ---------------------------------- 
 

Enquiries: Michelle Palmer, Assistant Company Secretary 01442 8867920

Consort Medical plc is a leading, global, single source pharma services drug and delivery device company. We are at the leading edge of innovation and we are committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.

Our businesses

Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, injectables and ocular products, and the manufacture of devices for the point of care diagnostics market. www.bespak.com.

Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners. www.aesica-pharma.com.

We employ more than 2000 people globally of which 1400 are located in the UK. We have UK facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Queenborough and Hemel Hempstead, German facilities in Monheim and Zwickau and a facility in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). www.consortmedical.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHFFLFLDQFBBBK

(END) Dow Jones Newswires

June 21, 2017 07:10 ET (11:10 GMT)